Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Balance Sheets

v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 1,196 $ 1,461
Accounts receivable 8,768 8,544
Other current assets 1,690 1,768
Total current assets 11,654 11,773
Property and equipment, net 1,277 1,361
Operating lease right of use assets 1,518 1,613
Other long-term assets 45 45
Total assets 14,494 14,792
Current liabilities:    
Accounts payable 1,733 1,659
Accrued salary and bonus 1,824 2,207
Other accrued expenses 1,696 1,799
Note payable at fair value 2,765 4,290
Current liabilities of discontinued operations 660 660
Total current liabilities 8,678 10,615
Operating lease liabilities, net of current portion 1,080 1,183
Other long-term liabilities 5,318 5,211
Total liabilities 15,076 17,009
Commitments and contingencies (Note 8)
Stockholders’ deficit:    
Redeemable preferred stock, $.01 par value; 5,000,000 shares authorized, 47,000 shares Series C issued and outstanding, respectively
Common stock, $.01 par value; 100,000,000 shares authorized; 4,560,999 and 4,539,663 shares issued, respectively; 4,423,093 and 4,409,323 shares outstanding, respectively 407 406
Additional paid-in capital 234,813 234,811
Accumulated deficit (233,733) (235,380)
Treasury stock, at cost (137,906 and 130,340 shares, respectively) (2,069) (2,054)
Total stockholders’ deficit (582) (2,217)
Total liabilities and stockholders’ deficit $ 14,494 $ 14,792